Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Status:
Terminated
Trial end date:
2011-03-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether IN-105 (oral insulin) is able to control increase
in blood glucose after eating a meal. This study will also tell whether single tablet of
IN-105 is safe for patients with Type 1 diabetes mellitus who are currently taking insulin
injections.